Darren S. Cline

SVP, Commercial, Seagen.

Companies

Xenon PharmaceuticalsChief Commercial Officer Jun 24, 2025 to now¹
Pliant (United States)Board member Mar 8, 2023 to now²
Pyxis Oncology, Inc.Board member Oct 7, 2021 to now³
Impel Neuropharma (United States)Board member Apr 13, 2023 to Jun 20, 2023⁴
SeagenSVP, Commercial Feb 17, 2015 to Nov 30, 2018⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pyxis Oncology, Inc. PYXS251,405 shares⁶$440.0K at $1.75Mar 26, 2024
Impel Neuropharma (United States)0 shares⁷Apr 13, 2023
Xenon Pharmaceuticals XENE0 shares⁸Jun 24, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 26, 2024Granted 35,219 shares of Pyxis Oncology, Inc.⁶
Mar 24, 2023Granted 139,355 shares of Pyxis Oncology, Inc.⁹
Mar 31, 2022Granted 66,831 shares of Pyxis Oncology, Inc.¹⁰
Dec 8, 2021Bought 10,000 shares at $9.39 of Pyxis Oncology, Inc.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXenon Pharmaceuticals, Chief Commercial Officer
2
SEC EDGARPliant (United States), Board member
3
SEC EDGARPyxis Oncology, Inc., Board member
4
SEC EDGARImpel Neuropharma (United States), Board member
5
SEC EDGARSeagen, SVP, Commercial
6
SEC EDGARPyxis Oncology, Inc. shares after the filing of Mar 26, 2024
7
SEC EDGARImpel Neuropharma (United States) shares after the filing of Apr 13, 2023
8
SEC EDGARXenon Pharmaceuticals shares after the filing of Jun 24, 2025
9
SEC EDGARForm 4 filed Mar 28, 2023
10
SEC EDGARForm 4 filed Apr 4, 2022
11
SEC EDGARForm 4 filed Dec 9, 2021